Zimmer Biomet Ownership
| ZIM Stock | EUR 101.45 0.10 0.1% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Zimmer |
Zimmer Stock Ownership Analysis
About 91.0% of the company outstanding shares are owned by institutional investors. The book value of Zimmer Biomet was at this time reported as 57.51. The company has Price/Earnings To Growth (PEG) ratio of 1.06. Zimmer Biomet Holdings last dividend was issued on the 23rd of December 2022. Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. ZIMMER BIOMET operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 19000 people. For more information please call the company at 574 267 6131 or visit https://www.zimmerbiomet.com.Zimmer Biomet Outstanding Bonds
Zimmer Biomet issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zimmer Biomet Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zimmer bonds can be classified according to their maturity, which is the date when Zimmer Biomet Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| ZIGGO BD FIN Corp BondUS98954UAB98 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAG72 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAF99 | View | |
| US98956PAB85 Corp BondUS98956PAB85 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAH55 | View | |
| ZBH 26 24 NOV 31 Corp BondUS98956PAV40 | View |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.